Nuclear translocation results in β-catenin acquiring tumor-promoting properties by activating the expression of various oncogenes such as fibronectin, cyclin D1, or c-myc, leading to deregulation of cell-cycle progression [47,64]. This evidence concerns the gene CCND1 and neoplasm.